Nasdaq Markets

The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Teledyne Technologies is now the #37 analyst pick, moving up by 197 spots.

The latest tally of analyst opinions from the major brokerage houses shows that among the 30 stocks making up the Dow Jones Industrial Average, UnitedHealth Group is the #2 analyst pick. UnitedHealth Group is also a top tier analyst pick among the broader S&P 500 index co

What happened? BioXcel Therapeutics (NASDAQ: BTAI) is starting the week on a strong note. As of 11:31 a.m. EDT on Monday, shares of the biotech company are up by 14.4%. There seem to be two major catalysts for these gains. First, BioXcel reported positive results from two clinic

U.S. lawmakers are set to begin debate on a second stimulus check as early as July 20, but Senate Majority Leader Mitch McConnell has hinted that the next check won't be as widely available as the first one. In fact, Sen. McConnell (R-Kentucky) recently said people with incomes

NEW YORK/MILAN/LONDON/HONG KONG (Reuters Breakingviews) - Corona Capital is a daily column updated throughout the day by Breakingviews columnists around the world with short, sharp pandemic-related insights.

BioNTech (NASDAQ: BNTX) and Pfizer (NYSE: PFE) released clinical trial results regarding the partners' experimental coronavirus vaccine program, BNT162, on Monday. Specifically, the partners published results from an early-stage German trial with BNT162b1, the most advanced can

What happened Shares of Chinese electric-vehicle maker NIO (NYSE: NIO) resumed their upward charge on Monday morning. The stock declined more than 25% last week amid notes from Wall Street analysts urging investors to be cautious. 

What happened Shares of PetMed Express (NASDAQ: PETS) were sinking 16.4% as of 11:24 a.m. EDT on Monday. The decline came after the pet pharmacy reported its fiscal 2021 first-quarter results before the market opened. PetMed delivered strong revenue and earnings growth, but  th

The Coronavirus Aid, Relief, and Economic Security (CARES) Act provided much-needed assistance to millions of American families who were struggling financially due to the lockdown necessitated by COVID-19. While the first coronavirus payments under the CARES Act weren't really e

In trading on Monday, shares of Mimecast Ltd (Symbol: MIME) crossed above their 200 day moving average of $41.45, changing hands as high as $42.77 per share. Mimecast Ltd shares are currently trading up about 3.2% on the day. The chart below shows the one year performance of

The COVID-19 pandemic has created unprecedented uncertainty in the financial markets, and Monday morning's market moves showed the impact that's having on market participants. Investors continue to see wide disparities in the way different stocks are moving, with growth-oriented

E-commerce is such an unstoppable force in our pandemic-stricken society that Goldman Sachs (NYSE: GS) analyst Terry Heath on Monday raised his price target for Amazon (NASDAQ: AMZN) to a level 28% above where the stock closed trading Friday.

In just a few months' time, a lot has changed. Many operations that rely on in-person interaction have been rendered redundant, and with digital businesses picking up the slack, it looks increasingly likely the world will never be the same. 

What happened Units of midstream master limited partnership Noble Midstream Partners (NYSE: NBLX) jumped as much as 17% when the trading day began on July 20. By roughly 10:30 a.m. Wall Street time, it was still hanging on to most of those gains, up around 14%. There was no news

At second-quarter 2020 earnings release, we expect investors to focus on Innoviva, Inc.’s INVA royalty revenues earned from a related party and the performance of the company’s portfolio of royalty assets.

Image source: Getty Images

Image source: Getty Images

(RTTNews) - Insurance software company Majesco (MJCO) announced Monday that it has signed a definitive agreement to be taken private by private equity firm Thoma Bravo, L.P. in a transaction valuing the company at $594 million.

In this episode of MarketFoolery, host Chris Hill chats with analyst Bill Mann about the latest financial reports and news from Wall Street. They talk about the recent Twitter (NYSE: TWTR) hack. A medical devices and consumer goods giant announced lower earnings, but bumped up i

(RTTNews) - Sorrento Therapeutics Inc. (SRNE) said that it received clearance from the FDA to initiate a Phase 2 trial of Abivertinib in patients with COVID-19 who have moderate to severe pulmonary symptoms.